dc.contributor.author |
Grobler, G.
|
|
dc.date.accessioned |
2013-11-12T13:49:03Z |
|
dc.date.available |
2013-11-12T13:49:03Z |
|
dc.date.issued |
2013-08 |
|
dc.description.abstract |
This treatment guideline draws on several international guidelines: (i) Practice Guidelines of the American Psychiatric Association (APA) for the Treatment of Patients with Major Depressive Disorder, Second Edition; (ii) Clinical Guidelines for the Treatment of Depressive Disorders by the Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments (CANMAT); (iii) National Institute for Clinical Excellence (NICE) guidelines; (iv) Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression (RANZCAP); (v) Texas Medication Algorithm Project (TMAP) Guidelines; (vi) World Federation of Societies of Biological Psychiatry (WFSBP) Treatment Guideline for Unipolar Depressive Disorder; and (vii) British Association for Psychopharmacology Guidelines. |
en_US |
dc.description.librarian |
am2013 |
en_US |
dc.description.librarian |
ay2013 |
en |
dc.description.uri |
http://www.sajp.org.za/index.php/sajp |
en_US |
dc.identifier.citation |
Grobler, G 2013, 'Major depressive disorder', South African Journal of Psychiatry, vol. 19, no. 3, pp. 157-163. |
en_US |
dc.identifier.issn |
1608-9685 (print) |
|
dc.identifier.issn |
2078-6786 (online) |
|
dc.identifier.uri |
http://hdl.handle.net/2263/32415 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Health and Medical Publishing Group |
en_US |
dc.rights |
Health and Medical Publishing Group |
en_US |
dc.subject |
Major depressive disorder (MDD) |
en_US |
dc.subject.lcsh |
Depression, Mental -- Treatment |
en |
dc.title |
Major depressive disorder |
en_US |
dc.type |
Article |
en_US |